Elisabeth Oelmann
Chief Tech/Sci/R&D Officer presso NUCANA PLC
Posizioni attive di Elisabeth Oelmann
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NUCANA PLC | Chief Tech/Sci/R&D Officer | 01/09/2020 | - |
Storia della carriera di Elisabeth Oelmann
Precedenti posizioni note di Elisabeth Oelmann
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
PRA International LLC
 PRA International LLC Pharmaceuticals: OtherHealth Technology Part of ICON plc, PRA International LLC is a clinical research organization. The private company is based in Raleigh, NC. | Corporate Officer/Principal | - | - |
| Freie Universität Berlin | Corporate Officer/Principal | - | - |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Chief Tech/Sci/R&D Officer | - | - |
Formazione di Elisabeth Oelmann
| University of Münster | Doctorate Degree |
Statistiche
Distribuzione geografica
| Germania | 3 |
| Regno Unito | 3 |
| Stati Uniti | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NUCANA PLC | Health Technology |
| Aziende private | 2 |
|---|---|
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
PRA International LLC
PRA International LLC Pharmaceuticals: OtherHealth Technology Part of ICON plc, PRA International LLC is a clinical research organization. The private company is based in Raleigh, NC. | Health Technology |
- Borsa valori
- Insiders
- Elisabeth Oelmann
- Esperienza
